# Polaryx Therapeutics, Inc.: Form S-1/A, filed Jan 14, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: S-1/A
- Filed: 2026-01-14
- Accepted by EDGAR: Jan 13, 2026, 19:30 ET
- Period: not reported
- Accession: 0001213900-26-004079
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/ea0251239-07.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/ea0251239-07.htm

Filed Jan 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-004079. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.